SEC Form 4 · accession 0001567619-19-005298
CODEXIS, INC. · CDXS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gordon Sangster
Officer — SVP & Chief Financial Officer
Period of report
Feb 20, 2019
Accepted (ET)
Feb 22, 2019 · 8:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001200375
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.95 | Feb 20, 2019 | A | 112,100 | A | — | Feb 20, 2028 | Common Stock | 112,100 | 112,100 | D |
| Stock Option (Right to Buy)F2 | $21.80 | Feb 20, 2019 | A | 25,000 | A | — | Feb 20, 2029 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1On February 20, 2018, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2018 with any remaining shares forfeited. On February 20, 2019, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 118% of the target level, which will result in the vesting of the option with respect to 56,050 shares on March 5, 2019 and 56,050 shares on March 5, 2020, in each case subject to the reporting person's continued service to the issuer through such vesting date.
- F2Option vests with respect to 25% of the shares subject thereto on February 20, 2020, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 20, 2023.